CLINICAL_TRIALS
trial_result
· 2014-02-17
Clinical Trial Update: Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study [Phase 2]
Summary
A Phase 2 clinical trial evaluated macitentan for idiopathic pulmonary fibrosis; the study has completed and results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actelion | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2014-02-17